• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST PAUL CADD CLEO INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST PAUL CADD CLEO INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 21-7230-24
Device Problem Material Fragmentation (1261)
Patient Problems Inflammation (1932); Skin Discoloration (2074); Device Embedded In Tissue or Plaque (3165)
Event Date 04/02/2019
Event Type  Injury  
Manufacturer Narrative
(b)(6).
 
Event Description
It was reported that a patient using the cleo device experienced a foreign body; needle retained in the abdomen.The patient's blood sugar levels were 11 mmol/l.The event occurred on (b)(6) 2019.Medical attention was sought, and the patient received an ultrasound and ct scan.The test results were inconclusive despite the physician feeling confident that a portion of the cannula had broken off under the patient's skin.The unbroken portions of the cannula were discarded by the patient.The physician ultimately opted to take a wait-and-see approach before scheduling a surgical removal.The physician reported some tenderness and redness at the affected site.The patient was scheduled to see a specialist in the upcoming 2-4 weeks.It was further reported that the patient followed up with the specialist.The specialist noted that the inflammation had resolved.There was some discoloration at the site however.This was considered abnormal given that several weeks had passed since the patient's initial consultation.The specialist recommended that the patient continue with the wait-and-see approach.The specialist also believed that the broken fragment was in-situ, and that there was potential for it to naturally be extruded without surgical removal.No further patient complications were reported in relation to this event.
 
Manufacturer Narrative
Correction: type of reportable event corrected from malfunction to serious injury.Evaluation results: four cadd cleo infusion devices were returned for investigation.The samples were visually inspected, at a distance of 12 to 24 inches and normal conditions of illumination.One of the samples was found to be broken.The customer reported product problem (fragmented device) was therefore confirmed.The product problem was attributed to a manufacturing problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD CLEO INFUSION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
MDR Report Key10098926
MDR Text Key193016903
Report Number3012307300-2020-05304
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,user facility
Type of Report Initial,Followup
Report Date 05/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number21-7230-24
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/16/2020
Was the Report Sent to FDA? No
Date Manufacturer Received12/31/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-